BioTech/Drugs - N/A, N/A, US
3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling activities.
Gmail
Apache
WordPress.org
Google Tag Manager
Mobile Friendly